Approval · Notice of Compliance 22890 · 2019
HALOPERIDOL INJECTION: Notice of Compliance 22890
Issued November 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22890
- Date
- November 12, 2019
- Company
- Neo Health Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- HALDOPERIDOL INJECTION, USP (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION | 02493993 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML